July 14, 2026 · Form 4 insider transaction
Gravier Pierre sold 3,494 shares of PTC Therapeutics, Inc. at $80.35 per share, a transaction worth $280.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a July 13, 2023 grant of 26,000 RSUs; Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026.